Oligonucleotide Synthesis Market Share

Statistics for the 2023 & 2024 Oligonucleotide Synthesis market share, created by Mordor Intelligenceā„¢ Industry Reports. Oligonucleotide Synthesis share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Oligonucleotide Synthesis Industry

The market is fragmented with the presence of a large number of players adopting various strategies, such as the acquisition of players in emerging markets, distribution partnerships, and collaboration for the development of novel technologies. The companies operating in the oligonucleotide synthesis industry are also expanding and developing their product portfolios, which helps drive the overall market and makes it fairly competitive. Some of the companies which are currently dominating the market are Agilent Technologies, Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Bio-Synthesis Inc., Eurofins Scientific, Kaneka Corporation (Eurogentec), GenScript, and LGC Limited (LGC Biosearch Technologies).

Oligonucleotide Synthesis Market Leaders

  1. Thermo Fisher Scientific

  2. Agilent Technologies

  3. Merck KGaA

  4. Bio-Synthesis Inc

  5. Eurofins Scientific

*Disclaimer: Major Players sorted in no particular order

Oligonucleotide Synthesis Market - cl.png

Oligonucleotide Synthesis Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)